Assignee
MEDIVIR AB
SE·91 granted patents·29 pending applications·920 citations·filing 1988–2024
Top patents by PatentIndex Score
120 records- 0197US9828408B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2016·Granted Nov 28, 2017·53 cites·11 claims
- 0296US9540411B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2016·Granted Jan 10, 2017·43 cites·17 claims
- 0396US9481703B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2015·Granted Nov 1, 2016·44 cites·23 claims
- 0494US7666856B2Antiviral nucleosidesMEDIVIR AB·Filed 2007·Granted Feb 23, 2010·36 cites·37 claims
- 0593US11447511B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Sep 20, 2022·2 cites·11 claims
- 0692US7601702B2Dutpase InhibitorsMEDIVIR AB·Filed 2005·Granted Oct 13, 2009·28 cites·22 claims
- 0791US7608590B2HCV NS-3 serine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Oct 27, 2009·23 cites·47 claims
- 0890US7700552B2Macrocyclic inhibitors of hepatitis C virusMEDIVIR AB·Filed 2006·Granted Apr 20, 2010·18 cites·12 claims
- 0990US7671032B2HCV NS-3 serine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 2, 2010·18 cites·57 claims
- 1089US10654877B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2019·Granted May 19, 2020·2 cites·12 claims
- 1189US10596220B2SMAC mimeticMEDIVIR AB·Filed 2019·Granted Mar 24, 2020·3 cites·13 claims
- 1288US10144750B2Dioxolane analogues of cytidine for the treatment of cancerMEDIVIR AB·Filed 2015·Granted Dec 4, 2018·6 cites·9 claims
- 1387US7825238B2Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosineMEDIVIR AB·Filed 2006·Granted Nov 2, 2010·5 cites·8 claims
- 1487US7071173B2Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosineMEDIVIR AB·Filed 2005·Granted Jul 4, 2006·5 cites·8 claims
- 1586US11351221B2SMAC mimeticMEDIVIR AB·Filed 2020·Granted Jun 7, 2022·1 cites·15 claims
- 1686US9200006B2Protease inhibitorsMEDIVIR AB·Filed 2014·Granted Dec 1, 2015·5 cites·8 claims
- 1786US8735395B2Protease inhibitorsMEDIVIR AB·Filed 2013·Granted May 27, 2014·5 cites·12 claims
- 1886US7893067B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2008·Granted Feb 22, 2011·8 cites·9 claims
- 1986US5576429A5-substituted pyrimidine nucleosides and nucleotidesMEDIVIR AB·Filed 1995·Granted Nov 19, 1996·51 cites·14 claims
- 2085US10336780B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2018·Granted Jul 2, 2019·3 cites·10 claims
- 2185US2023382931A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2023·Application pending·0 cites
- 2284US11951147B2SMAC mimeticMEDIVIR AB·Filed 2022·Granted Apr 9, 2024·0 cites·17 claims
- 2384US10822360B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Nov 3, 2020·1 cites·13 claims
- 2484US5473063ASynthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analoguesMEDIVIR AB·Filed 1991·Granted Dec 5, 1995·34 cites·2 claims
- 2584US5284837ADerivatives of purine, process for their preparation and a pharmaceutical preparationMEDIVIR AB·Filed 1989·Granted Feb 8, 1994·17 cites·15 claims
- 2683US12378209B2Protease inhibitorsMEDIVIR AB·Filed 2022·Granted Aug 5, 2025·0 cites·1 claims
- 2783US10723709B2Protease inhibitorsMEDIVIR AB·Filed 2019·Granted Jul 28, 2020·1 cites·18 claims
- 2883US10456413B2Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabineMEDIVIR AB·Filed 2017·Granted Oct 29, 2019·2 cites·20 claims
- 2983US6703394B2Acyclic nucleoside derivativesMEDIVIR AB·Filed 2002·Granted Mar 9, 2004·12 cites·12 claims
- 3083US6458772B1ProdrugsMEDIVIR AB·Filed 1999·Granted Oct 1, 2002·53 cites·12 claims
- 3183US5714503ACompounds and methods for inhibition of HIV and related virusesMEDIVIR AB·Filed 1995·Granted Feb 3, 1998·27 cites·16 claims
- 3283US5593993AMethod for inhibition of HIV related virusesMEDIVIR AB·Filed 1995·Granted Jan 14, 1997·62 cites·9 claims
- 3382US7189849B2Synthesis of acyclic nucleoside derivativesMEDIVIR AB·Filed 2005·Granted Mar 13, 2007·6 cites·14 claims
- 3481US7825239B2Antiviral nucleosidesMEDIVIR AB·Filed 2010·Granted Nov 2, 2010·6 cites·1 claims
- 3581US2023117570A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2022·Application pending·0 cites
- 3681US2023190696A1Pharmaceutical Formulation for Histone Deacetylase InhibitorsMEDIVIR AB·Filed 2023·Application pending·0 cites
- 3779US7795270B2DUTPase inhibitorsMEDIVIR AB·Filed 2005·Granted Sep 14, 2010·3 cites·13 claims
- 3877US5446029AAnti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosidesMEDIVIR AB·Filed 1993·Granted Aug 29, 1995·42 cites·3 claims
- 3976US12303521B2Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibodyMEDIVIR AB·Filed 2020·Granted May 20, 2025·1 cites·18 claims
- 4076US6337324B1Pharmaceutical combinationMEDIVIR AB·Filed 1996·Granted Jan 8, 2002·43 cites·36 claims
- 4175US7935681B2Antiviral nucleosidesMEDIVIR AB·Filed 2010·Granted May 3, 2011·2 cites·4 claims
- 4275US5215971AAntiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosidesMEDIVIR AB·Filed 1991·Granted Jun 1, 1993·40 cites·15 claims
- 4374US11607399B2Pharmaceutical formulation for histone deacetylase inhibitorsMEDIVIR AB·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 4474US6974802B2Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosineMEDIVIR AB·Filed 2001·Granted Dec 13, 2005·4 cites·13 claims
- 4574US5849769AN-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infectionMEDIVIR AB·Filed 1994·Granted Dec 15, 1998·36 cites·37 claims
- 4673US12479870B2Base-modified cytidine nucleotides for leukemia therapyMEDIVIR AB·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 4773US11312693B2Protease inhibitorsMEDIVIR AB·Filed 2020·Granted Apr 26, 2022·0 cites·3 claims
- 4872US10960017B2Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancerMEDIVIR AB·Filed 2019·Granted Mar 30, 2021·1 cites·15 claims
- 4972US5440040APyrimidine intermediatesMEDIVIR AB·Filed 1989·Granted Aug 8, 1995·13 cites·2 claims
- 5072US2010075924A1Dutpase inhibitorsMEDIVIR AB·Filed 2009·Application pending·0 cites
Showing the top 50 of 120 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEDIVIR AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →